AlloSource

AlloSource Announces Two Presentations at the North American Spine Society Annual Meeting

Centennial, Colo. — September 25, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced two presentations on the use of biologics in spinal fusion surgery at AlloSource’s booth #2031 at the North American Spine Society (NASS) Annual Meeting on Thursday, September 27. Dr. Wellington K. Hsu will present on Novel Allograft Processing Methods to Improve Osteoinductivity and Clinical Outcomes at 12:10 p.m. Dr. Hsu is a Professor of Orthopaedic Surgery and Neurological Surgery at Northwestern University Feinberg School of Medicine in Chicago, Illinois and specializes in degenerative spine surgery, cervical spine surgery,…

AlloSource Named One of the 100 Healthiest Workplaces in America by Healthiest Employers

Centennial, Colo. — September 21, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in America. Over 1,000 organizations across the United States applied for the award, which measures employees on six essential values: vision, culture/engagement, learning, expertise, metrics and technology. Healthiest Employers’ annual “Healthiest 100 Workplaces in America” program honors leaders in corporate wellness and rewards employers that demonstrate a strategic vision for their company’s role in the overall healthcare environment. “We are honored to receive this…

AlloSource Awards Dr. Kevin Shea the Annual Dr. Steven Gitelis Inspiration Award

Centennial, Colo. — July 17, 2018 — AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award Dr. Kevin Shea with its second annual Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with allografts. Dr. Shea recently joined the Stanford University School of Medicine as a professor of orthopedic surgery and also serves as director of the…

AlloSource Partners With Tuition.io to Help Employees Pay Down Student Debt

Centennial, Colo. — May 1, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced the rollout of its student loan repayment assistance program, a new employee benefit to help workers pay off their student loans faster. The company is partnering with Tuition.io, the leading platform for employee student loan contributions, to administer the program. As part of the benefit, AlloSource employees will receive monthly contributions to help pay down the principal of their student loans. According to Willis Towers Watson, only 4% of companies in the United States offer…

AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft

Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical and biochemical properties of normal hyaline cartilage, restore a smooth articular cartilage surface, help relieve patient symptoms, and improve function. AlloSource launched ProChondrix in 2016 and developed a cryopreserved version to provide a longer shelf-life, while maintaining the high cellular viability of the product1. “ProChondrix CR demonstrates our commitment to innovation and our surgeon customers,” said Kerr…

AlloSource Co-Authors International Space Station Microbial Study with NASA’s Jet Propulsion Laboratory

Centennial, Colo. — January 16, 2018 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts, and NASA’s Jet Propulsion Laboratory (JPL) co-authored a scientific publication titled “Detection of antimicrobial resistance genes associated with the International Space Station environmental surfaces” that was published today in Nature’s Scientific Reports. Manned space flights have always been accompanied by the human microbiome, which travels with the astronauts through the duration of the missions and remains on the International Space Station (ISS). Previous studies on the ISS have acknowledged and identified many of the microbes capable of surviving…

AlloSource Launches Placental Donation Program

Centennial, Colo. — December 20, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts that advance patient healing, today announced the launch of the AlloSource Placental Donation Program. This initiative provides the opportunity for women undergoing scheduled caesarean sections to collaborate with AlloSource and their doctor to facilitate the donation of placental tissue following delivery. AlloSource will work directly with physicians, hospitals, and expectant mothers who are interested in donating their placental tissue following an elective C-section. The first hospital AlloSource is partnering with on the initiative is Lutheran Medical Center in…

AlloSource Announces Raime Leeby Muhle As Chief Financial Officer

Centennial, Colo. — December 14, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Raime Leeby Muhle as Chief Financial Officer. With over 18 years of experience, her background spans from emerging high growth businesses to large and mature organizations. She has worked in a variety of industries including technology, distribution, manufacturing, and telecommunications. Leeby Muhle’s expertise in complex environments, as well as working cross-functionally, will help her lead the accounting, financial, and information technology…

American Heart Association Recognizes AlloSource For Workplace Health Achievements

Centennial, Colo. — December 5, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced it received recognition from the American Heart Association for promoting a workplace culture of health and well-being. The American Heart Association’s Workplace Health Achievement Index scores companies of all sizes on 55 best practices in seven categories: leadership, engagement, programs, policies and environment, partnerships, communications, and reporting outcomes. AlloSource received Silver-level recognition for its health and wellness efforts. “Our role in healthcare gives us…

AlloSource Announces Bob Lay As Chief Operating Officer

Centennial, Colo. — November 7, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer. With over 20 years of experience in both finance and operations, Bob has a broad-based understanding of how each department within an organization impacts another. He has an extensive background working with businesses and medical device companies to conduct operational audits, improve processes and systems, and balance the needs of many departments to drive company…